Jpmorgan Chase & CO Inovio Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 26, 2024	BUY	$0.35 - $0.53 $4,725 - $7,155	13,500 New	13,500 $6,000
Q4 2023 Feb 12, 2024	SELL	$0.35 - $0.53 $17,032 - $25,792	-48,665 Reduced 78.28%	13,500 $6,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $1.12 Million - $1.71 Million	-2,956,317 Reduced 97.94%	62,165 $24,000
Q2 2023 Aug 11, 2023	SELL	$0.39 - $0.94 $99,678 - $240,249	-255,585 Reduced 7.81%	3,018,482 $1.36 Million
Q1 2023 May 18, 2023	BUY	$0.79 - $1.91 $149,595 - $361,679	189,361 Added 6.14%	3,274,067 $2.68 Million
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $151,895 - $367,241	-192,273 Reduced 5.87%	3,084,706 $2.53 Million
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.5 $30,042 - $53,267	-21,307 Reduced 0.65%	3,276,979 $5.11 Million
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $227,693 - $382,690	-137,165 Reduced 3.99%	3,298,286 $5.69 Million
Q2 2022 Aug 11, 2022	SELL	$1.44 - $3.98 $7,729 - $21,364	-5,368 Reduced 0.16%	3,435,451 $5.94 Million
Q1 2022 May 11, 2022	SELL	$2.97 - $5.2 $1.06 Million - $1.86 Million	-357,059 Reduced 9.4%	3,440,819 $12.4 Million
Q4 2021 Feb 10, 2022	SELL	$4.99 - $7.46 $1.55 Million - $2.31 Million	-309,941 Reduced 7.55%	3,797,878 $19 Million
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $29.4 Million - $39.8 Million	4,107,819 New	4,107,819 $29.4 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $506M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.